SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '1pbk'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1BKF_A_FK5A108_1 (FK506 BINDING PROTEIN)	1pbk	FKBP25 (Homo sapiens)	7 / 9	TYR A 135 ASP A 146 VAL A 171 ILE A 172 TRP A 175 TYR A 198 PHE A 216	RAP A 225 (-3.9A) RAP A 225 (-3.0A) RAP A 225 (-3.5A) RAP A 225 (-3.9A) RAP A 225 (-3.4A) RAP A 225 (-4.6A) None	0.30A	1bkfA-1pbkA: 19.1	1bkfA-1pbkA: 44.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1C9H_A_RAPA108_1 (FKBP12.6)	1pbk	FKBP25 (Homo sapiens)	7 / 12	TYR A 135 ASP A 146 VAL A 171 ILE A 172 TYR A 198 ILE A 208 PHE A 216	RAP A 225 (-3.9A) RAP A 225 (-3.0A) RAP A 225 (-3.5A) RAP A 225 (-3.9A) RAP A 225 (-4.6A) RAP A 225 ( 4.9A) None	0.41A	1c9hA-1pbkA: 18.8	1c9hA-1pbkA: 42.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1FAP_A_RAPA108_1 (FK506-BINDING PROTEIN)	1pbk	FKBP25 (Homo sapiens)	8 / 12	TYR A 135 ASP A 146 VAL A 171 ILE A 172 TRP A 175 TYR A 198 ILE A 208 PHE A 216	RAP A 225 (-3.9A) RAP A 225 (-3.0A) RAP A 225 (-3.5A) RAP A 225 (-3.9A) RAP A 225 (-3.4A) RAP A 225 (-4.6A) RAP A 225 ( 4.9A) None	0.32A	1fapA-1pbkA: 19.6	1fapA-1pbkA: 43.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1FKB_A_RAPA108_1 (FK506 BINDING PROTEIN)	1pbk	FKBP25 (Homo sapiens)	7 / 12	TYR A 135 ASP A 146 VAL A 171 ILE A 172 TRP A 175 TYR A 198 PHE A 216	RAP A 225 (-3.9A) RAP A 225 (-3.0A) RAP A 225 (-3.5A) RAP A 225 (-3.9A) RAP A 225 (-3.4A) RAP A 225 (-4.6A) None	0.29A	1fkbA-1pbkA: 19.6	1fkbA-1pbkA: 43.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1FKF_A_FK5A108_1 (FK506 BINDING PROTEIN)	1pbk	FKBP25 (Homo sapiens)	8 / 11	TYR A 135 ASP A 146 VAL A 171 ILE A 172 TRP A 175 TYR A 198 ILE A 208 PHE A 216	RAP A 225 (-3.9A) RAP A 225 (-3.0A) RAP A 225 (-3.5A) RAP A 225 (-3.9A) RAP A 225 (-3.4A) RAP A 225 (-4.6A) RAP A 225 ( 4.9A) None	0.37A	1fkfA-1pbkA: 19.3	1fkfA-1pbkA: 43.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1FKJ_A_FK5A108_1 (FK506 BINDING PROTEIN)	1pbk	FKBP25 (Homo sapiens)	6 / 11	PHE A 164 ILE A 172 TRP A 175 TYR A 198 ILE A 208 PHE A 216	None RAP A 225 (-3.9A) RAP A 225 (-3.4A) RAP A 225 (-4.6A) RAP A 225 ( 4.9A) None	1.40A	1fkjA-1pbkA: 19.3	1fkjA-1pbkA: 43.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1FKJ_A_FK5A108_1 (FK506 BINDING PROTEIN)	1pbk	FKBP25 (Homo sapiens)	8 / 11	TYR A 135 ASP A 146 VAL A 171 ILE A 172 TRP A 175 TYR A 198 ILE A 208 PHE A 216	RAP A 225 (-3.9A) RAP A 225 (-3.0A) RAP A 225 (-3.5A) RAP A 225 (-3.9A) RAP A 225 (-3.4A) RAP A 225 (-4.6A) RAP A 225 ( 4.9A) None	0.38A	1fkjA-1pbkA: 19.3	1fkjA-1pbkA: 43.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1FKL_A_RAPA108_1 (FK506 BINDING PROTEIN)	1pbk	FKBP25 (Homo sapiens)	8 / 12	TYR A 135 ASP A 146 VAL A 171 ILE A 172 TRP A 175 TYR A 198 ILE A 208 PHE A 216	RAP A 225 (-3.9A) RAP A 225 (-3.0A) RAP A 225 (-3.5A) RAP A 225 (-3.9A) RAP A 225 (-3.4A) RAP A 225 (-4.6A) RAP A 225 ( 4.9A) None	0.31A	1fklA-1pbkA: 19.6	1fklA-1pbkA: 44.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1Q6I_A_FK5A301_1 (FKBP-TYPE PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKPA)	1pbk	FKBP25 (Homo sapiens)	9 / 9	TYR A 135 ASP A 146 LEU A 162 VAL A 171 ILE A 172 TRP A 175 TYR A 198 ILE A 208 PHE A 216	RAP A 225 (-3.9A) RAP A 225 (-3.0A) RAP A 225 (-4.8A) RAP A 225 (-3.5A) RAP A 225 (-3.9A) RAP A 225 (-3.4A) RAP A 225 (-4.6A) RAP A 225 ( 4.9A) None	0.60A	1q6iA-1pbkA: 15.7	1q6iA-1pbkA: 25.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1Q6I_B_FK5B401_1 (FKBP-TYPE PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKPA)	1pbk	FKBP25 (Homo sapiens)	8 / 10	TYR A 135 ASP A 146 VAL A 171 ILE A 172 TRP A 175 TYR A 198 ILE A 208 PHE A 216	RAP A 225 (-3.9A) RAP A 225 (-3.0A) RAP A 225 (-3.5A) RAP A 225 (-3.9A) RAP A 225 (-3.4A) RAP A 225 (-4.6A) RAP A 225 ( 4.9A) None	0.36A	1q6iB-1pbkA: 15.4	1q6iB-1pbkA: 25.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1TCO_C_FK5C509_2 (FK506-BINDING PROTEIN)	1pbk	FKBP25 (Homo sapiens)	8 / 11	TYR A 135 ASP A 146 VAL A 171 ILE A 172 TRP A 175 TYR A 198 ILE A 208 PHE A 216	RAP A 225 (-3.9A) RAP A 225 (-3.0A) RAP A 225 (-3.5A) RAP A 225 (-3.9A) RAP A 225 (-3.4A) RAP A 225 (-4.6A) RAP A 225 ( 4.9A) None	0.33A	1tcoC-1pbkA: 18.9	1tcoC-1pbkA: 43.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1YAT_A_FK5A108_1 (FK506 BINDING PROTEIN)	1pbk	FKBP25 (Homo sapiens)	8 / 11	TYR A 135 ASP A 146 VAL A 171 ILE A 172 TRP A 175 TYR A 198 ILE A 208 PHE A 216	RAP A 225 (-3.9A) RAP A 225 (-3.0A) RAP A 225 (-3.5A) RAP A 225 (-3.9A) RAP A 225 (-3.4A) RAP A 225 (-4.6A) RAP A 225 ( 4.9A) None	0.29A	1yatA-1pbkA: 19.4	1yatA-1pbkA: 40.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2DG3_A_RAPA501_1 (FK506-BINDING PROTEIN 1A)	1pbk	FKBP25 (Homo sapiens)	7 / 11	TYR A 135 ASP A 146 VAL A 171 ILE A 172 TRP A 175 TYR A 198 PHE A 216	RAP A 225 (-3.9A) RAP A 225 (-3.0A) RAP A 225 (-3.5A) RAP A 225 (-3.9A) RAP A 225 (-3.4A) RAP A 225 (-4.6A) None	0.32A	2dg3A-1pbkA: 19.4	2dg3A-1pbkA: 43.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2DG4_A_RAPA501_1 (FK506-BINDING PROTEIN 1A)	1pbk	FKBP25 (Homo sapiens)	6 / 11	TYR A 135 ASP A 146 VAL A 171 ILE A 172 TYR A 198 PHE A 216	RAP A 225 (-3.9A) RAP A 225 (-3.0A) RAP A 225 (-3.5A) RAP A 225 (-3.9A) RAP A 225 (-4.6A) None	0.33A	2dg4A-1pbkA: 18.8	2dg4A-1pbkA: 42.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2DG9_A_RAPA501_1 (FK506-BINDING PROTEIN 1A)	1pbk	FKBP25 (Homo sapiens)	6 / 11	TYR A 135 ASP A 146 VAL A 171 ILE A 172 TYR A 198 PHE A 216	RAP A 225 (-3.9A) RAP A 225 (-3.0A) RAP A 225 (-3.5A) RAP A 225 (-3.9A) RAP A 225 (-4.6A) None	0.35A	2dg9A-1pbkA: 19.1	2dg9A-1pbkA: 42.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2FKE_A_FK5A108_1 (FK506 BINDING PROTEIN)	1pbk	FKBP25 (Homo sapiens)	8 / 11	TYR A 135 ASP A 146 VAL A 171 ILE A 172 TRP A 175 TYR A 198 ILE A 208 PHE A 216	RAP A 225 (-3.9A) RAP A 225 (-3.0A) RAP A 225 (-3.5A) RAP A 225 (-3.9A) RAP A 225 (-3.4A) RAP A 225 (-4.6A) RAP A 225 ( 4.9A) None	0.36A	2fkeA-1pbkA: 19.3	2fkeA-1pbkA: 43.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2HS2_B_017B203_1 (PROTEASE)	1pbk	FKBP25 (Homo sapiens)	4 / 6	TRP A 196 LEU A 179 ARG A 173 GLY A 169	None None None RAP A 225 (-3.8A)	1.21A	2hs2B-1pbkA: undetectable	2hs2B-1pbkA: 21.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2VCD_A_RAPA138_1 (OUTER MEMBRANE PROTEIN MIP)	1pbk	FKBP25 (Homo sapiens)	6 / 11	TYR A 135 PHE A 145 ASP A 146 VAL A 171 ILE A 172 TRP A 175	RAP A 225 (-3.9A) RAP A 225 (-4.6A) RAP A 225 (-3.0A) RAP A 225 (-3.5A) RAP A 225 (-3.9A) RAP A 225 (-3.4A)	0.75A	2vcdA-1pbkA: 13.4	2vcdA-1pbkA: 31.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2VCD_A_RAPA138_1 (OUTER MEMBRANE PROTEIN MIP)	1pbk	FKBP25 (Homo sapiens)	6 / 11	TYR A 135 PHE A 145 VAL A 171 ILE A 172 TRP A 175 TYR A 198	RAP A 225 (-3.9A) RAP A 225 (-4.6A) RAP A 225 (-3.5A) RAP A 225 (-3.9A) RAP A 225 (-3.4A) RAP A 225 (-4.6A)	0.94A	2vcdA-1pbkA: 13.4	2vcdA-1pbkA: 31.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2VN1_A_FK5A501_1 (70 KDA PEPTIDYLPROLYL ISOMERASE)	1pbk	FKBP25 (Homo sapiens)	8 / 11	TYR A 135 PHE A 145 ASP A 146 VAL A 171 TRP A 175 TYR A 198 ILE A 208 PHE A 216	RAP A 225 (-3.9A) RAP A 225 (-4.6A) RAP A 225 (-3.0A) RAP A 225 (-3.5A) RAP A 225 (-3.4A) RAP A 225 (-4.6A) RAP A 225 ( 4.9A) None	0.36A	2vn1A-1pbkA: 18.1	2vn1A-1pbkA: 35.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2VN1_B_FK5B501_1 (70 KDA PEPTIDYLPROLYL ISOMERASE)	1pbk	FKBP25 (Homo sapiens)	7 / 10	TYR A 135 ASP A 146 VAL A 171 ILE A 172 TRP A 175 TYR A 198 PHE A 216	RAP A 225 (-3.9A) RAP A 225 (-3.0A) RAP A 225 (-3.5A) RAP A 225 (-3.9A) RAP A 225 (-3.4A) RAP A 225 (-4.6A) None	0.28A	2vn1B-1pbkA: 18.1	2vn1B-1pbkA: 35.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3IHZ_A_FK5A501_1 (70 KDA PEPTIDYLPROLYL ISOMERASE, PUTATIVE)	1pbk	FKBP25 (Homo sapiens)	8 / 10	TYR A 135 ASP A 146 VAL A 171 ILE A 172 TRP A 175 TYR A 198 ILE A 208 PHE A 216	RAP A 225 (-3.9A) RAP A 225 (-3.0A) RAP A 225 (-3.5A) RAP A 225 (-3.9A) RAP A 225 (-3.4A) RAP A 225 (-4.6A) RAP A 225 ( 4.9A) None	0.42A	3ihzA-1pbkA: 18.1	3ihzA-1pbkA: 33.08
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3IHZ_A_FK5A501_2 (70 KDA PEPTIDYLPROLYL ISOMERASE, PUTATIVE)	1pbk	FKBP25 (Homo sapiens)	4 / 8	TYR A 135 TRP A 175 TYR A 198 ILE A 208	RAP A 225 (-3.9A) RAP A 225 (-3.4A) RAP A 225 (-4.6A) RAP A 225 ( 4.9A)	0.49A	3ihzB-1pbkA: 18.2	3ihzB-1pbkA: 33.08
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3KZ7_A_RAPA225_1 (FK506-BINDING PROTEIN 3)	1pbk	FKBP25 (Homo sapiens)	10 / 10	TYR A 135 ASP A 146 LEU A 162 LYS A 170 VAL A 171 ILE A 172 TRP A 175 TYR A 198 ILE A 208 PHE A 216	RAP A 225 (-3.9A) RAP A 225 (-3.0A) RAP A 225 (-4.8A) RAP A 225 (-2.9A) RAP A 225 (-3.5A) RAP A 225 (-3.9A) RAP A 225 (-3.4A) RAP A 225 (-4.6A) RAP A 225 ( 4.9A) None	0.41A	3kz7A-1pbkA: 22.7	3kz7A-1pbkA: 95.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3O5R_A_FK5A1001_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5)	1pbk	FKBP25 (Homo sapiens)	8 / 11	TYR A 135 ASP A 146 VAL A 171 ILE A 172 TRP A 175 TYR A 198 ILE A 208 PHE A 216	RAP A 225 (-3.9A) RAP A 225 (-3.0A) RAP A 225 (-3.5A) RAP A 225 (-3.9A) RAP A 225 (-3.4A) RAP A 225 (-4.6A) RAP A 225 ( 4.9A) None	0.30A	3o5rA-1pbkA: 18.3	3o5rA-1pbkA: 37.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3O5R_A_FK5A1001_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5)	1pbk	FKBP25 (Homo sapiens)	8 / 11	TYR A 135 ASP A 146 VAL A 171 ILE A 172 TYR A 198 LYS A 207 ILE A 208 PHE A 216	RAP A 225 (-3.9A) RAP A 225 (-3.0A) RAP A 225 (-3.5A) RAP A 225 (-3.9A) RAP A 225 (-4.6A) None RAP A 225 ( 4.9A) None	0.54A	3o5rA-1pbkA: 18.3	3o5rA-1pbkA: 37.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3UF8_A_FK5A114_1 (UBIQUITIN-LIKE PROTEIN SMT3, PEPTIDYL-PROLYL CIS-TRANS ISOMERASE)	1pbk	FKBP25 (Homo sapiens)	8 / 10	TYR A 135 ASP A 146 VAL A 171 ILE A 172 TRP A 175 TYR A 198 ILE A 208 PHE A 216	RAP A 225 (-3.9A) RAP A 225 (-3.0A) RAP A 225 (-3.5A) RAP A 225 (-3.9A) RAP A 225 (-3.4A) RAP A 225 (-4.6A) RAP A 225 ( 4.9A) None	0.24A	3uf8A-1pbkA: 18.1	3uf8A-1pbkA: 26.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3UQA_A_FK5A114_1 (UBIQUITIN-LIKE PROTEIN SMT3, PEPTIDYL-PROLYL CIS-TRANS ISOMERASE)	1pbk	FKBP25 (Homo sapiens)	8 / 10	TYR A 135 ASP A 146 VAL A 171 ILE A 172 TRP A 175 TYR A 198 ILE A 208 PHE A 216	RAP A 225 (-3.9A) RAP A 225 (-3.0A) RAP A 225 (-3.5A) RAP A 225 (-3.9A) RAP A 225 (-3.4A) RAP A 225 (-4.6A) RAP A 225 ( 4.9A) None	0.31A	3uqaA-1pbkA: 18.0	3uqaA-1pbkA: 26.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3UQB_A_FK5A114_1 (UBIQUITIN-LIKE PROTEIN SMT3, PEPTIDYL-PROLYL CIS-TRANS ISOMERASE)	1pbk	FKBP25 (Homo sapiens)	7 / 8	TYR A 135 VAL A 171 ILE A 172 TRP A 175 TYR A 198 ILE A 208 PHE A 216	RAP A 225 (-3.9A) RAP A 225 (-3.5A) RAP A 225 (-3.9A) RAP A 225 (-3.4A) RAP A 225 (-4.6A) RAP A 225 ( 4.9A) None	0.26A	3uqbA-1pbkA: 17.9	3uqbA-1pbkA: 26.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3VAW_A_FK5A114_1 (UBIQUITIN-LIKE PROTEIN SMT3,PEPTIDYL-PROLYL CIS-TRANS ISOMERASE)	1pbk	FKBP25 (Homo sapiens)	8 / 11	TYR A 135 ASP A 146 VAL A 171 ILE A 172 TRP A 175 TYR A 198 ILE A 208 PHE A 216	RAP A 225 (-3.9A) RAP A 225 (-3.0A) RAP A 225 (-3.5A) RAP A 225 (-3.9A) RAP A 225 (-3.4A) RAP A 225 (-4.6A) RAP A 225 ( 4.9A) None	0.32A	3vawA-1pbkA: 17.4	3vawA-1pbkA: 26.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DRH_A_RAPA201_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5)	1pbk	FKBP25 (Homo sapiens)	8 / 12	TYR A 135 ASP A 146 VAL A 171 ILE A 172 TRP A 175 TYR A 198 ILE A 208 PHE A 216	RAP A 225 (-3.9A) RAP A 225 (-3.0A) RAP A 225 (-3.5A) RAP A 225 (-3.9A) RAP A 225 (-3.4A) RAP A 225 (-4.6A) RAP A 225 ( 4.9A) None	0.39A	4drhA-1pbkA: 17.3	4drhA-1pbkA: 38.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DRH_D_RAPD201_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5)	1pbk	FKBP25 (Homo sapiens)	8 / 12	TYR A 135 ASP A 146 VAL A 171 ILE A 172 TRP A 175 TYR A 198 ILE A 208 PHE A 216	RAP A 225 (-3.9A) RAP A 225 (-3.0A) RAP A 225 (-3.5A) RAP A 225 (-3.9A) RAP A 225 (-3.4A) RAP A 225 (-4.6A) RAP A 225 ( 4.9A) None	0.38A	4drhD-1pbkA: 17.3	4drhD-1pbkA: 38.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DRI_A_RAPA201_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5)	1pbk	FKBP25 (Homo sapiens)	8 / 11	TYR A 135 ASP A 146 VAL A 171 ILE A 172 TRP A 175 TYR A 198 ILE A 208 PHE A 216	RAP A 225 (-3.9A) RAP A 225 (-3.0A) RAP A 225 (-3.5A) RAP A 225 (-3.9A) RAP A 225 (-3.4A) RAP A 225 (-4.6A) RAP A 225 ( 4.9A) None	0.33A	4driA-1pbkA: 18.8	4driA-1pbkA: 38.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DRJ_A_RAPA201_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP4)	1pbk	FKBP25 (Homo sapiens)	8 / 11	TYR A 135 ASP A 146 VAL A 171 ILE A 172 TRP A 175 TYR A 198 ILE A 208 PHE A 216	RAP A 225 (-3.9A) RAP A 225 (-3.0A) RAP A 225 (-3.5A) RAP A 225 (-3.9A) RAP A 225 (-3.4A) RAP A 225 (-4.6A) RAP A 225 ( 4.9A) None	0.26A	4drjA-1pbkA: 19.1	4drjA-1pbkA: 38.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DZ2_A_FK5A200_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE)	1pbk	FKBP25 (Homo sapiens)	5 / 11	PHE A 164 ILE A 172 TRP A 175 TYR A 198 PHE A 216	None RAP A 225 (-3.9A) RAP A 225 (-3.4A) RAP A 225 (-4.6A) None	1.36A	4dz2A-1pbkA: 17.9 4dz2B-1pbkA: 17.9	4dz2A-1pbkA: 41.32 4dz2B-1pbkA: 41.32
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DZ2_A_FK5A200_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE)	1pbk	FKBP25 (Homo sapiens)	8 / 11	TYR A 135 ASP A 146 VAL A 171 ILE A 172 TRP A 175 TYR A 198 ILE A 208 PHE A 216	RAP A 225 (-3.9A) RAP A 225 (-3.0A) RAP A 225 (-3.5A) RAP A 225 (-3.9A) RAP A 225 (-3.4A) RAP A 225 (-4.6A) RAP A 225 ( 4.9A) None	0.31A	4dz2A-1pbkA: 17.9 4dz2B-1pbkA: 17.9	4dz2A-1pbkA: 41.32 4dz2B-1pbkA: 41.32
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DZ2_B_FK5B200_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE)	1pbk	FKBP25 (Homo sapiens)	6 / 11	PHE A 164 ILE A 172 TRP A 175 TYR A 198 ILE A 208 PHE A 216	None RAP A 225 (-3.9A) RAP A 225 (-3.4A) RAP A 225 (-4.6A) RAP A 225 ( 4.9A) None	1.36A	4dz2A-1pbkA: 17.9 4dz2B-1pbkA: 17.9	4dz2A-1pbkA: 41.32 4dz2B-1pbkA: 41.32
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DZ2_B_FK5B200_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE)	1pbk	FKBP25 (Homo sapiens)	8 / 11	TYR A 135 ASP A 146 VAL A 171 ILE A 172 TRP A 175 TYR A 198 ILE A 208 PHE A 216	RAP A 225 (-3.9A) RAP A 225 (-3.0A) RAP A 225 (-3.5A) RAP A 225 (-3.9A) RAP A 225 (-3.4A) RAP A 225 (-4.6A) RAP A 225 ( 4.9A) None	0.32A	4dz2A-1pbkA: 17.9 4dz2B-1pbkA: 17.9	4dz2A-1pbkA: 41.32 4dz2B-1pbkA: 41.32
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DZ3_A_FK5A201_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE)	1pbk	FKBP25 (Homo sapiens)	5 / 10	PHE A 164 ILE A 172 TRP A 175 TYR A 198 PHE A 216	None RAP A 225 (-3.9A) RAP A 225 (-3.4A) RAP A 225 (-4.6A) None	1.33A	4dz3A-1pbkA: 18.1	4dz3A-1pbkA: 41.32
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DZ3_A_FK5A201_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE)	1pbk	FKBP25 (Homo sapiens)	8 / 10	TYR A 135 ASP A 146 VAL A 171 ILE A 172 TRP A 175 TYR A 198 ILE A 208 PHE A 216	RAP A 225 (-3.9A) RAP A 225 (-3.0A) RAP A 225 (-3.5A) RAP A 225 (-3.9A) RAP A 225 (-3.4A) RAP A 225 (-4.6A) RAP A 225 ( 4.9A) None	0.32A	4dz3A-1pbkA: 18.1	4dz3A-1pbkA: 41.32
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DZ3_B_FK5B201_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE)	1pbk	FKBP25 (Homo sapiens)	6 / 10	PHE A 164 ILE A 172 TRP A 175 TYR A 198 ILE A 208 PHE A 216	None RAP A 225 (-3.9A) RAP A 225 (-3.4A) RAP A 225 (-4.6A) RAP A 225 ( 4.9A) None	1.33A	4dz3B-1pbkA: 18.1	4dz3B-1pbkA: 41.32
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4DZ3_B_FK5B201_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE)	1pbk	FKBP25 (Homo sapiens)	8 / 10	TYR A 135 ASP A 146 VAL A 171 ILE A 172 TRP A 175 TYR A 198 ILE A 208 PHE A 216	RAP A 225 (-3.9A) RAP A 225 (-3.0A) RAP A 225 (-3.5A) RAP A 225 (-3.9A) RAP A 225 (-3.4A) RAP A 225 (-4.6A) RAP A 225 ( 4.9A) None	0.31A	4dz3B-1pbkA: 18.1	4dz3B-1pbkA: 41.32
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4LAX_A_FK5A301_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP4)	1pbk	FKBP25 (Homo sapiens)	6 / 10	PHE A 164 ILE A 172 TRP A 175 TYR A 198 ILE A 208 PHE A 216	None RAP A 225 (-3.9A) RAP A 225 (-3.4A) RAP A 225 (-4.6A) RAP A 225 ( 4.9A) None	1.47A	4laxA-1pbkA: 19.1	4laxA-1pbkA: 33.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4LAX_A_FK5A301_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP4)	1pbk	FKBP25 (Homo sapiens)	8 / 10	TYR A 135 ASP A 146 VAL A 171 ILE A 172 TRP A 175 LYS A 207 ILE A 208 PHE A 216	RAP A 225 (-3.9A) RAP A 225 (-3.0A) RAP A 225 (-3.5A) RAP A 225 (-3.9A) RAP A 225 (-3.4A) None RAP A 225 ( 4.9A) None	0.71A	4laxA-1pbkA: 19.1	4laxA-1pbkA: 33.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4LAX_A_FK5A301_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP4)	1pbk	FKBP25 (Homo sapiens)	8 / 10	TYR A 135 ASP A 146 VAL A 171 ILE A 172 TRP A 175 TYR A 198 ILE A 208 PHE A 216	RAP A 225 (-3.9A) RAP A 225 (-3.0A) RAP A 225 (-3.5A) RAP A 225 (-3.9A) RAP A 225 (-3.4A) RAP A 225 (-4.6A) RAP A 225 ( 4.9A) None	0.28A	4laxA-1pbkA: 19.1	4laxA-1pbkA: 33.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4NNR_A_FK5A201_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP2)	1pbk	FKBP25 (Homo sapiens)	8 / 12	TYR A 135 ASP A 146 VAL A 171 ILE A 172 TRP A 175 TYR A 198 ILE A 208 PHE A 216	RAP A 225 (-3.9A) RAP A 225 (-3.0A) RAP A 225 (-3.5A) RAP A 225 (-3.9A) RAP A 225 (-3.4A) RAP A 225 (-4.6A) RAP A 225 ( 4.9A) None	0.27A	4nnrA-1pbkA: 15.6 4nnrB-1pbkA: 15.6	4nnrA-1pbkA: 38.62 4nnrB-1pbkA: 38.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4NNR_B_FK5B201_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP2)	1pbk	FKBP25 (Homo sapiens)	8 / 10	TYR A 135 ASP A 146 VAL A 171 ILE A 172 TRP A 175 TYR A 198 ILE A 208 PHE A 216	RAP A 225 (-3.9A) RAP A 225 (-3.0A) RAP A 225 (-3.5A) RAP A 225 (-3.9A) RAP A 225 (-3.4A) RAP A 225 (-4.6A) RAP A 225 ( 4.9A) None	0.26A	4nnrB-1pbkA: 15.6	4nnrB-1pbkA: 38.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ODO_A_FK5A205_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE SLYD)	1pbk	FKBP25 (Homo sapiens)	6 / 10	TYR A 135 ASP A 146 LEU A 162 ILE A 172 TYR A 198 PHE A 216	RAP A 225 (-3.9A) RAP A 225 (-3.0A) RAP A 225 (-4.8A) RAP A 225 (-3.9A) RAP A 225 (-4.6A) None	0.54A	4odoA-1pbkA: 11.6	4odoA-1pbkA: 27.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ODO_B_FK5B203_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE SLYD)	1pbk	FKBP25 (Homo sapiens)	6 / 10	TYR A 135 ASP A 146 LEU A 162 ILE A 172 TYR A 198 PHE A 216	RAP A 225 (-3.9A) RAP A 225 (-3.0A) RAP A 225 (-4.8A) RAP A 225 (-3.9A) RAP A 225 (-4.6A) None	0.52A	4odoB-1pbkA: 11.4	4odoB-1pbkA: 27.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ODO_C_FK5C204_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE SLYD)	1pbk	FKBP25 (Homo sapiens)	6 / 10	TYR A 135 ASP A 146 LEU A 162 ILE A 172 TYR A 198 PHE A 216	RAP A 225 (-3.9A) RAP A 225 (-3.0A) RAP A 225 (-4.8A) RAP A 225 (-3.9A) RAP A 225 (-4.6A) None	0.51A	4odoC-1pbkA: 11.2	4odoC-1pbkA: 27.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ODR_A_FK5A201_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE SLYD, PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP1A CHIMERA)	1pbk	FKBP25 (Homo sapiens)	7 / 12	TYR A 135 ASP A 146 LEU A 162 ILE A 172 TYR A 198 ILE A 208 PHE A 216	RAP A 225 (-3.9A) RAP A 225 (-3.0A) RAP A 225 (-4.8A) RAP A 225 (-3.9A) RAP A 225 (-4.6A) RAP A 225 ( 4.9A) None	0.49A	4odrA-1pbkA: 13.2 4odrB-1pbkA: 13.2	4odrA-1pbkA: 28.06 4odrB-1pbkA: 28.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ODR_B_FK5B201_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE SLYD, PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP1A CHIMERA)	1pbk	FKBP25 (Homo sapiens)	6 / 11	TYR A 135 ASP A 146 LEU A 162 ILE A 172 TYR A 198 PHE A 216	RAP A 225 (-3.9A) RAP A 225 (-3.0A) RAP A 225 (-4.8A) RAP A 225 (-3.9A) RAP A 225 (-4.6A) None	0.48A	4odrA-1pbkA: 13.2 4odrB-1pbkA: 13.2	4odrA-1pbkA: 28.06 4odrB-1pbkA: 28.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4QT2_A_RAPA202_1 (FK506-BINDING PROTEIN (FKBP)-TYPE PEPTIDYL-PROPYL ISOMERASE)	1pbk	FKBP25 (Homo sapiens)	8 / 10	TYR A 135 ASP A 146 VAL A 171 ILE A 172 TRP A 175 TYR A 198 ILE A 208 PHE A 216	RAP A 225 (-3.9A) RAP A 225 (-3.0A) RAP A 225 (-3.5A) RAP A 225 (-3.9A) RAP A 225 (-3.4A) RAP A 225 (-4.6A) RAP A 225 ( 4.9A) None	0.31A	4qt2A-1pbkA: 18.5	4qt2A-1pbkA: 37.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4QT3_A_RAPA202_1 (FK506-BINDING PROTEIN (FKBP)-TYPE PEPTIDYL-PROPYL ISOMERASE)	1pbk	FKBP25 (Homo sapiens)	8 / 10	TYR A 135 ASP A 146 VAL A 171 ILE A 172 TRP A 175 TYR A 198 ILE A 208 PHE A 216	RAP A 225 (-3.9A) RAP A 225 (-3.0A) RAP A 225 (-3.5A) RAP A 225 (-3.9A) RAP A 225 (-3.4A) RAP A 225 (-4.6A) RAP A 225 ( 4.9A) None	0.37A	4qt3A-1pbkA: 17.4	4qt3A-1pbkA: 33.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5B8I_C_FK5C201_3 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE)	1pbk	FKBP25 (Homo sapiens)	8 / 12	TYR A 135 ASP A 146 VAL A 171 ILE A 172 TRP A 175 TYR A 198 ILE A 208 PHE A 216	RAP A 225 (-3.9A) RAP A 225 (-3.0A) RAP A 225 (-3.5A) RAP A 225 (-3.9A) RAP A 225 (-3.4A) RAP A 225 (-4.6A) RAP A 225 ( 4.9A) None	0.34A	5b8iC-1pbkA: 18.9	5b8iC-1pbkA: 41.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5D75_A_FK5A301_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP3)	1pbk	FKBP25 (Homo sapiens)	9 / 11	LEU A 162 VAL A 171 ILE A 172 TRP A 175 TYR A 198 GLN A 203 ALA A 206 ILE A 208 PHE A 216	RAP A 225 (-4.8A) RAP A 225 (-3.5A) RAP A 225 (-3.9A) RAP A 225 (-3.4A) RAP A 225 (-4.6A) None RAP A 225 ( 3.9A) RAP A 225 ( 4.9A) None	1.05A	5d75A-1pbkA: 22.0	5d75A-1pbkA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5D75_A_FK5A301_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP3)	1pbk	FKBP25 (Homo sapiens)	10 / 11	TYR A 135 ASP A 146 LEU A 162 VAL A 171 ILE A 172 TRP A 175 TYR A 198 ALA A 206 ILE A 208 PHE A 216	RAP A 225 (-3.9A) RAP A 225 (-3.0A) RAP A 225 (-4.8A) RAP A 225 (-3.5A) RAP A 225 (-3.9A) RAP A 225 (-3.4A) RAP A 225 (-4.6A) RAP A 225 ( 3.9A) RAP A 225 ( 4.9A) None	0.75A	5d75A-1pbkA: 22.0	5d75A-1pbkA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5GPG_A_RAPA301_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP3)	1pbk	FKBP25 (Homo sapiens)	10 / 11	TYR A 135 ASP A 146 LEU A 162 LYS A 170 VAL A 171 ILE A 172 TRP A 175 TYR A 198 ILE A 208 PHE A 216	RAP A 225 (-3.9A) RAP A 225 (-3.0A) RAP A 225 (-4.8A) RAP A 225 (-2.9A) RAP A 225 (-3.5A) RAP A 225 (-3.9A) RAP A 225 (-3.4A) RAP A 225 (-4.6A) RAP A 225 ( 4.9A) None	0.54A	5gpgA-1pbkA: 21.9	5gpgA-1pbkA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5GPG_A_RAPA301_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP3)	1pbk	FKBP25 (Homo sapiens)	10 / 11	TYR A 135 ASP A 146 LEU A 162 VAL A 171 ILE A 172 TRP A 175 TYR A 198 ALA A 206 ILE A 208 PHE A 216	RAP A 225 (-3.9A) RAP A 225 (-3.0A) RAP A 225 (-4.8A) RAP A 225 (-3.5A) RAP A 225 (-3.9A) RAP A 225 (-3.4A) RAP A 225 (-4.6A) RAP A 225 ( 3.9A) RAP A 225 ( 4.9A) None	0.56A	5gpgA-1pbkA: 21.9	5gpgA-1pbkA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5HKG_A_RAPA201_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP1B)	1pbk	FKBP25 (Homo sapiens)	7 / 12	TYR A 135 ASP A 146 VAL A 171 ILE A 172 TYR A 198 ILE A 208 PHE A 216	RAP A 225 (-3.9A) RAP A 225 (-3.0A) RAP A 225 (-3.5A) RAP A 225 (-3.9A) RAP A 225 (-4.6A) RAP A 225 ( 4.9A) None	0.38A	5hkgA-1pbkA: 19.1	5hkgA-1pbkA: 42.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5HUA_A_FK5A201_1 (FK506-BINDING PROTEIN 1)	1pbk	FKBP25 (Homo sapiens)	7 / 11	TYR A 135 ASP A 146 VAL A 171 ILE A 172 TRP A 175 TYR A 198 PHE A 216	RAP A 225 (-3.9A) RAP A 225 (-3.0A) RAP A 225 (-3.5A) RAP A 225 (-3.9A) RAP A 225 (-3.4A) RAP A 225 (-4.6A) None	0.25A	5huaA-1pbkA: 19.6	5huaA-1pbkA: 42.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5HW8_A_FK5A201_1 (FK506-BINDING PROTEIN 1)	1pbk	FKBP25 (Homo sapiens)	7 / 11	TYR A 135 ASP A 146 VAL A 171 ILE A 172 TRP A 175 TYR A 198 ILE A 208	RAP A 225 (-3.9A) RAP A 225 (-3.0A) RAP A 225 (-3.5A) RAP A 225 (-3.9A) RAP A 225 (-3.4A) RAP A 225 (-4.6A) RAP A 225 ( 4.9A)	0.45A	5hw8A-1pbkA: 17.9 5hw8D-1pbkA: 18.1	5hw8A-1pbkA: 40.00 5hw8D-1pbkA: 40.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5HW8_B_FK5B201_1 (FK506-BINDING PROTEIN 1)	1pbk	FKBP25 (Homo sapiens)	7 / 11	TYR A 135 ASP A 146 VAL A 171 TRP A 175 TYR A 198 ILE A 208 PHE A 216	RAP A 225 (-3.9A) RAP A 225 (-3.0A) RAP A 225 (-3.5A) RAP A 225 (-3.4A) RAP A 225 (-4.6A) RAP A 225 ( 4.9A) None	0.40A	5hw8B-1pbkA: 17.9	5hw8B-1pbkA: 40.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5HW8_C_FK5C201_1 (FK506-BINDING PROTEIN 1)	1pbk	FKBP25 (Homo sapiens)	8 / 10	TYR A 135 ASP A 146 VAL A 171 ILE A 172 TRP A 175 TYR A 198 LEU A 214 PHE A 216	RAP A 225 (-3.9A) RAP A 225 (-3.0A) RAP A 225 (-3.5A) RAP A 225 (-3.9A) RAP A 225 (-3.4A) RAP A 225 (-4.6A) None None	0.41A	5hw8C-1pbkA: 17.8 5hw8H-1pbkA: 14.8	5hw8C-1pbkA: 40.00 5hw8H-1pbkA: 40.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5HW8_D_FK5D201_1 (FK506-BINDING PROTEIN 1)	1pbk	FKBP25 (Homo sapiens)	8 / 11	TYR A 135 ASP A 146 VAL A 171 ILE A 172 TRP A 175 TYR A 198 ILE A 208 PHE A 216	RAP A 225 (-3.9A) RAP A 225 (-3.0A) RAP A 225 (-3.5A) RAP A 225 (-3.9A) RAP A 225 (-3.4A) RAP A 225 (-4.6A) RAP A 225 ( 4.9A) None	0.40A	5hw8D-1pbkA: 18.1	5hw8D-1pbkA: 40.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5HW8_E_FK5E201_1 (FK506-BINDING PROTEIN 1)	1pbk	FKBP25 (Homo sapiens)	7 / 11	TYR A 135 ASP A 146 VAL A 171 ILE A 172 TRP A 175 TYR A 198 ILE A 208	RAP A 225 (-3.9A) RAP A 225 (-3.0A) RAP A 225 (-3.5A) RAP A 225 (-3.9A) RAP A 225 (-3.4A) RAP A 225 (-4.6A) RAP A 225 ( 4.9A)	1.46A	5hw8E-1pbkA: 18.3	5hw8E-1pbkA: 40.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5HW8_E_FK5E201_1 (FK506-BINDING PROTEIN 1)	1pbk	FKBP25 (Homo sapiens)	7 / 11	TYR A 135 ASP A 146 VAL A 171 ILE A 172 TRP A 175 TYR A 198 PHE A 216	RAP A 225 (-3.9A) RAP A 225 (-3.0A) RAP A 225 (-3.5A) RAP A 225 (-3.9A) RAP A 225 (-3.4A) RAP A 225 (-4.6A) None	0.42A	5hw8E-1pbkA: 18.3	5hw8E-1pbkA: 40.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5HW8_F_FK5F201_1 (FK506-BINDING PROTEIN 1)	1pbk	FKBP25 (Homo sapiens)	7 / 12	TYR A 135 ASP A 146 VAL A 171 ILE A 172 TRP A 175 TYR A 198 PHE A 216	RAP A 225 (-3.9A) RAP A 225 (-3.0A) RAP A 225 (-3.5A) RAP A 225 (-3.9A) RAP A 225 (-3.4A) RAP A 225 (-4.6A) None	0.41A	5hw8B-1pbkA: 17.9 5hw8F-1pbkA: 15.0 5hw8G-1pbkA: 17.4	5hw8B-1pbkA: 40.00 5hw8F-1pbkA: 40.00 5hw8G-1pbkA: 40.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5HW8_G_FK5G201_2 (FK506-BINDING PROTEIN 1)	1pbk	FKBP25 (Homo sapiens)	7 / 11	TYR A 135 ASP A 146 VAL A 171 ILE A 172 TRP A 175 TYR A 198 ILE A 208	RAP A 225 (-3.9A) RAP A 225 (-3.0A) RAP A 225 (-3.5A) RAP A 225 (-3.9A) RAP A 225 (-3.4A) RAP A 225 (-4.6A) RAP A 225 ( 4.9A)	1.41A	5hw8G-1pbkA: 17.4	5hw8G-1pbkA: 40.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5HW8_G_FK5G201_2 (FK506-BINDING PROTEIN 1)	1pbk	FKBP25 (Homo sapiens)	8 / 11	TYR A 135 ASP A 146 VAL A 171 ILE A 172 TRP A 175 TYR A 198 ILE A 208 PHE A 216	RAP A 225 (-3.9A) RAP A 225 (-3.0A) RAP A 225 (-3.5A) RAP A 225 (-3.9A) RAP A 225 (-3.4A) RAP A 225 (-4.6A) RAP A 225 ( 4.9A) None	0.38A	5hw8G-1pbkA: 17.4	5hw8G-1pbkA: 40.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5HW8_H_FK5H201_1 (FK506-BINDING PROTEIN 1)	1pbk	FKBP25 (Homo sapiens)	6 / 8	TYR A 135 ASP A 146 VAL A 171 ILE A 172 TRP A 175 PHE A 216	RAP A 225 (-3.9A) RAP A 225 (-3.0A) RAP A 225 (-3.5A) RAP A 225 (-3.9A) RAP A 225 (-3.4A) None	0.53A	5hw8H-1pbkA: 14.8	5hw8H-1pbkA: 40.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5HWC_A_FK5A201_1 (FK506-BINDING PROTEIN 1A)	1pbk	FKBP25 (Homo sapiens)	8 / 11	TYR A 135 ASP A 146 VAL A 171 ILE A 172 TRP A 175 TYR A 198 ILE A 208 PHE A 216	RAP A 225 (-3.9A) RAP A 225 (-3.0A) RAP A 225 (-3.5A) RAP A 225 (-3.9A) RAP A 225 (-3.4A) RAP A 225 (-4.6A) RAP A 225 ( 4.9A) None	0.30A	5hwcA-1pbkA: 19.6	5hwcA-1pbkA: 43.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5JLC_A_1YNA602_2 (LANOSTEROL 14-ALPHA DEMETHYLASE)	1pbk	FKBP25 (Homo sapiens)	4 / 5	GLY A 142 THR A 143 GLY A 119 LEU A 190	None	0.91A	5jlcA-1pbkA: undetectable	5jlcA-1pbkA: 12.90
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6MKE_A_FK5A201_0 (PEPTIDYLPROLYL ISOMERASE)	1pbk	FKBP25 (Homo sapiens)	8 / 12	TYR A 135 ASP A 146 VAL A 171 ILE A 172 TRP A 175 TYR A 198 ILE A 208 PHE A 216	RAP A 225 (-3.9A) RAP A 225 (-3.0A) RAP A 225 (-3.5A) RAP A 225 (-3.9A) RAP A 225 (-3.4A) RAP A 225 (-4.6A) RAP A 225 ( 4.9A) None	0.40A	6mkeA-1pbkA: 18.1 6mkeD-1pbkA: 18.1	6mkeA-1pbkA: 36.99 6mkeD-1pbkA: 36.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6MKE_B_FK5B201_0 (PEPTIDYLPROLYL ISOMERASE)	1pbk	FKBP25 (Homo sapiens)	8 / 12	TYR A 135 ASP A 146 VAL A 171 ILE A 172 TRP A 175 TYR A 198 ILE A 208 PHE A 216	RAP A 225 (-3.9A) RAP A 225 (-3.0A) RAP A 225 (-3.5A) RAP A 225 (-3.9A) RAP A 225 (-3.4A) RAP A 225 (-4.6A) RAP A 225 ( 4.9A) None	0.40A	6mkeB-1pbkA: 18.1 6mkeC-1pbkA: 18.3	6mkeB-1pbkA: 36.99 6mkeC-1pbkA: 36.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6MKE_C_FK5C201_1 (PEPTIDYLPROLYL ISOMERASE)	1pbk	FKBP25 (Homo sapiens)	8 / 10	TYR A 135 ASP A 146 VAL A 171 ILE A 172 TRP A 175 TYR A 198 ILE A 208 PHE A 216	RAP A 225 (-3.9A) RAP A 225 (-3.0A) RAP A 225 (-3.5A) RAP A 225 (-3.9A) RAP A 225 (-3.4A) RAP A 225 (-4.6A) RAP A 225 ( 4.9A) None	0.33A	6mkeC-1pbkA: 18.3	6mkeC-1pbkA: 36.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6MKE_D_FK5D201_1 (PEPTIDYLPROLYL ISOMERASE)	1pbk	FKBP25 (Homo sapiens)	8 / 10	TYR A 135 ASP A 146 VAL A 171 ILE A 172 TRP A 175 TYR A 198 ILE A 208 PHE A 216	RAP A 225 (-3.9A) RAP A 225 (-3.0A) RAP A 225 (-3.5A) RAP A 225 (-3.9A) RAP A 225 (-3.4A) RAP A 225 (-4.6A) RAP A 225 ( 4.9A) None	0.39A	6mkeD-1pbkA: 18.1	6mkeD-1pbkA: 36.99

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1BKF_A_FK5A108_1","FK506 BINDING PROTEIN","1pbk","FKBP25","Homo sapiens",7,"TYR A 135;ASP A 146;VAL A 171;ILE A 172;TRP A 175;TYR A 198;PHE A 216","RAP A 225 (-3.9A);RAP A 225 (-3.0A);RAP A 225 (-3.5A);RAP A 225 (-3.9A);RAP A 225 (-3.4A);RAP A 225 (-4.6A);None","0.30A","1bkfA-1pbkA:19.1","1bkfA-1pbkA:44.17"],["1C9H_A_RAPA108_1","FKBP12.6","1pbk","FKBP25","Homo sapiens",7,"TYR A 135;ASP A 146;VAL A 171;ILE A 172;TYR A 198;ILE A 208;PHE A 216","RAP A 225 (-3.9A);RAP A 225 (-3.0A);RAP A 225 (-3.5A);RAP A 225 (-3.9A);RAP A 225 (-4.6A);RAP A 225 ( 4.9A);None","0.41A","1c9hA-1pbkA:18.8","1c9hA-1pbkA:42.50"],["1FAP_A_RAPA108_1","FK506-BINDING PROTEIN","1pbk","FKBP25","Homo sapiens",8,"TYR A 135;ASP A 146;VAL A 171;ILE A 172;TRP A 175;TYR A 198;ILE A 208;PHE A 216","RAP A 225 (-3.9A);RAP A 225 (-3.0A);RAP A 225 (-3.5A);RAP A 225 (-3.9A);RAP A 225 (-3.4A);RAP A 225 (-4.6A);RAP A 225 ( 4.9A);None","0.32A","1fapA-1pbkA:19.6","1fapA-1pbkA:43.33"],["1FKB_A_RAPA108_1","FK506 BINDING PROTEIN","1pbk","FKBP25","Homo sapiens",7,"TYR A 135;ASP A 146;VAL A 171;ILE A 172;TRP A 175;TYR A 198;PHE A 216","RAP A 225 (-3.9A);RAP A 225 (-3.0A);RAP A 225 (-3.5A);RAP A 225 (-3.9A);RAP A 225 (-3.4A);RAP A 225 (-4.6A);None","0.29A","1fkbA-1pbkA:19.6","1fkbA-1pbkA:43.33"],["1FKF_A_FK5A108_1","FK506 BINDING PROTEIN","1pbk","FKBP25","Homo sapiens",8,"TYR A 135;ASP A 146;VAL A 171;ILE A 172;TRP A 175;TYR A 198;ILE A 208;PHE A 216","RAP A 225 (-3.9A);RAP A 225 (-3.0A);RAP A 225 (-3.5A);RAP A 225 (-3.9A);RAP A 225 (-3.4A);RAP A 225 (-4.6A);RAP A 225 ( 4.9A);None","0.37A","1fkfA-1pbkA:19.3","1fkfA-1pbkA:43.33"],["1FKJ_A_FK5A108_1","FK506 BINDING PROTEIN","1pbk","FKBP25","Homo sapiens",6,"PHE A 164;ILE A 172;TRP A 175;TYR A 198;ILE A 208;PHE A 216","None;RAP A 225 (-3.9A);RAP A 225 (-3.4A);RAP A 225 (-4.6A);RAP A 225 ( 4.9A);None","1.40A","1fkjA-1pbkA:19.3","1fkjA-1pbkA:43.33"],["1FKJ_A_FK5A108_1","FK506 BINDING PROTEIN","1pbk","FKBP25","Homo sapiens",8,"TYR A 135;ASP A 146;VAL A 171;ILE A 172;TRP A 175;TYR A 198;ILE A 208;PHE A 216","RAP A 225 (-3.9A);RAP A 225 (-3.0A);RAP A 225 (-3.5A);RAP A 225 (-3.9A);RAP A 225 (-3.4A);RAP A 225 (-4.6A);RAP A 225 ( 4.9A);None","0.38A","1fkjA-1pbkA:19.3","1fkjA-1pbkA:43.33"],["1FKL_A_RAPA108_1","FK506 BINDING PROTEIN","1pbk","FKBP25","Homo sapiens",8,"TYR A 135;ASP A 146;VAL A 171;ILE A 172;TRP A 175;TYR A 198;ILE A 208;PHE A 216","RAP A 225 (-3.9A);RAP A 225 (-3.0A);RAP A 225 (-3.5A);RAP A 225 (-3.9A);RAP A 225 (-3.4A);RAP A 225 (-4.6A);RAP A 225 ( 4.9A);None","0.31A","1fklA-1pbkA:19.6","1fklA-1pbkA:44.17"],["1Q6I_A_FK5A301_1","FKBP-TYPE PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKPA","1pbk","FKBP25","Homo sapiens",9,"TYR A 135;ASP A 146;LEU A 162;VAL A 171;ILE A 172;TRP A 175;TYR A 198;ILE A 208;PHE A 216","RAP A 225 (-3.9A);RAP A 225 (-3.0A);RAP A 225 (-4.8A);RAP A 225 (-3.5A);RAP A 225 (-3.9A);RAP A 225 (-3.4A);RAP A 225 (-4.6A);RAP A 225 ( 4.9A);None","0.60A","1q6iA-1pbkA:15.7","1q6iA-1pbkA:25.65"],["1Q6I_B_FK5B401_1","FKBP-TYPE PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKPA","1pbk","FKBP25","Homo sapiens",8,"TYR A 135;ASP A 146;VAL A 171;ILE A 172;TRP A 175;TYR A 198;ILE A 208;PHE A 216","RAP A 225 (-3.9A);RAP A 225 (-3.0A);RAP A 225 (-3.5A);RAP A 225 (-3.9A);RAP A 225 (-3.4A);RAP A 225 (-4.6A);RAP A 225 ( 4.9A);None","0.36A","1q6iB-1pbkA:15.4","1q6iB-1pbkA:25.65"],["1TCO_C_FK5C509_2","FK506-BINDING PROTEIN","1pbk","FKBP25","Homo sapiens",8,"TYR A 135;ASP A 146;VAL A 171;ILE A 172;TRP A 175;TYR A 198;ILE A 208;PHE A 216","RAP A 225 (-3.9A);RAP A 225 (-3.0A);RAP A 225 (-3.5A);RAP A 225 (-3.9A);RAP A 225 (-3.4A);RAP A 225 (-4.6A);RAP A 225 ( 4.9A);None","0.33A","1tcoC-1pbkA:18.9","1tcoC-1pbkA:43.33"],["1YAT_A_FK5A108_1","FK506 BINDING PROTEIN","1pbk","FKBP25","Homo sapiens",8,"TYR A 135;ASP A 146;VAL A 171;ILE A 172;TRP A 175;TYR A 198;ILE A 208;PHE A 216","RAP A 225 (-3.9A);RAP A 225 (-3.0A);RAP A 225 (-3.5A);RAP A 225 (-3.9A);RAP A 225 (-3.4A);RAP A 225 (-4.6A);RAP A 225 ( 4.9A);None","0.29A","1yatA-1pbkA:19.4","1yatA-1pbkA:40.50"],["2DG3_A_RAPA501_1","FK506-BINDING PROTEIN 1A","1pbk","FKBP25","Homo sapiens",7,"TYR A 135;ASP A 146;VAL A 171;ILE A 172;TRP A 175;TYR A 198;PHE A 216","RAP A 225 (-3.9A);RAP A 225 (-3.0A);RAP A 225 (-3.5A);RAP A 225 (-3.9A);RAP A 225 (-3.4A);RAP A 225 (-4.6A);None","0.32A","2dg3A-1pbkA:19.4","2dg3A-1pbkA:43.33"],["2DG4_A_RAPA501_1","FK506-BINDING PROTEIN 1A","1pbk","FKBP25","Homo sapiens",6,"TYR A 135;ASP A 146;VAL A 171;ILE A 172;TYR A 198;PHE A 216","RAP A 225 (-3.9A);RAP A 225 (-3.0A);RAP A 225 (-3.5A);RAP A 225 (-3.9A);RAP A 225 (-4.6A);None","0.33A","2dg4A-1pbkA:18.8","2dg4A-1pbkA:42.50"],["2DG9_A_RAPA501_1","FK506-BINDING PROTEIN 1A","1pbk","FKBP25","Homo sapiens",6,"TYR A 135;ASP A 146;VAL A 171;ILE A 172;TYR A 198;PHE A 216","RAP A 225 (-3.9A);RAP A 225 (-3.0A);RAP A 225 (-3.5A);RAP A 225 (-3.9A);RAP A 225 (-4.6A);None","0.35A","2dg9A-1pbkA:19.1","2dg9A-1pbkA:42.50"],["2FKE_A_FK5A108_1","FK506 BINDING PROTEIN","1pbk","FKBP25","Homo sapiens",8,"TYR A 135;ASP A 146;VAL A 171;ILE A 172;TRP A 175;TYR A 198;ILE A 208;PHE A 216","RAP A 225 (-3.9A);RAP A 225 (-3.0A);RAP A 225 (-3.5A);RAP A 225 (-3.9A);RAP A 225 (-3.4A);RAP A 225 (-4.6A);RAP A 225 ( 4.9A);None","0.36A","2fkeA-1pbkA:19.3","2fkeA-1pbkA:43.33"],["2HS2_B_017B203_1","PROTEASE","1pbk","FKBP25","Homo sapiens",4,"TRP A 196;LEU A 179;ARG A 173;GLY A 169","None;None;None;RAP A 225 (-3.8A)","1.21A","2hs2B-1pbkA:undetectable","2hs2B-1pbkA:21.37"],["2VCD_A_RAPA138_1","OUTER MEMBRANE PROTEIN MIP","1pbk","FKBP25","Homo sapiens",6,"TYR A 135;PHE A 145;ASP A 146;VAL A 171;ILE A 172;TRP A 175","RAP A 225 (-3.9A);RAP A 225 (-4.6A);RAP A 225 (-3.0A);RAP A 225 (-3.5A);RAP A 225 (-3.9A);RAP A 225 (-3.4A)","0.75A","2vcdA-1pbkA:13.4","2vcdA-1pbkA:31.76"],["2VCD_A_RAPA138_1","OUTER MEMBRANE PROTEIN MIP","1pbk","FKBP25","Homo sapiens",6,"TYR A 135;PHE A 145;VAL A 171;ILE A 172;TRP A 175;TYR A 198","RAP A 225 (-3.9A);RAP A 225 (-4.6A);RAP A 225 (-3.5A);RAP A 225 (-3.9A);RAP A 225 (-3.4A);RAP A 225 (-4.6A)","0.94A","2vcdA-1pbkA:13.4","2vcdA-1pbkA:31.76"],["2VN1_A_FK5A501_1","70 KDA PEPTIDYLPROLYL ISOMERASE","1pbk","FKBP25","Homo sapiens",8,"TYR A 135;PHE A 145;ASP A 146;VAL A 171;TRP A 175;TYR A 198;ILE A 208;PHE A 216","RAP A 225 (-3.9A);RAP A 225 (-4.6A);RAP A 225 (-3.0A);RAP A 225 (-3.5A);RAP A 225 (-3.4A);RAP A 225 (-4.6A);RAP A 225 ( 4.9A);None","0.36A","2vn1A-1pbkA:18.1","2vn1A-1pbkA:35.82"],["2VN1_B_FK5B501_1","70 KDA PEPTIDYLPROLYL ISOMERASE","1pbk","FKBP25","Homo sapiens",7,"TYR A 135;ASP A 146;VAL A 171;ILE A 172;TRP A 175;TYR A 198;PHE A 216","RAP A 225 (-3.9A);RAP A 225 (-3.0A);RAP A 225 (-3.5A);RAP A 225 (-3.9A);RAP A 225 (-3.4A);RAP A 225 (-4.6A);None","0.28A","2vn1B-1pbkA:18.1","2vn1B-1pbkA:35.82"],["3IHZ_A_FK5A501_1","70 KDA PEPTIDYLPROLYL ISOMERASE, PUTATIVE","1pbk","FKBP25","Homo sapiens",8,"TYR A 135;ASP A 146;VAL A 171;ILE A 172;TRP A 175;TYR A 198;ILE A 208;PHE A 216","RAP A 225 (-3.9A);RAP A 225 (-3.0A);RAP A 225 (-3.5A);RAP A 225 (-3.9A);RAP A 225 (-3.4A);RAP A 225 (-4.6A);RAP A 225 ( 4.9A);None","0.42A","3ihzA-1pbkA:18.1","3ihzA-1pbkA:33.08"],["3IHZ_A_FK5A501_2","70 KDA PEPTIDYLPROLYL ISOMERASE, PUTATIVE;70 KDA PEPTIDYLPROLYL ISOMERASE, PUTATIVE","1pbk","FKBP25","Homo sapiens",4,"TYR A 135;TRP A 175;TYR A 198;ILE A 208","RAP A 225 (-3.9A);RAP A 225 (-3.4A);RAP A 225 (-4.6A);RAP A 225 ( 4.9A)","0.49A","3ihzB-1pbkA:18.2","3ihzB-1pbkA:33.08"],["3KZ7_A_RAPA225_1","FK506-BINDING PROTEIN 3","1pbk","FKBP25","Homo sapiens",10,"TYR A 135;ASP A 146;LEU A 162;LYS A 170;VAL A 171;ILE A 172;TRP A 175;TYR A 198;ILE A 208;PHE A 216","RAP A 225 (-3.9A);RAP A 225 (-3.0A);RAP A 225 (-4.8A);RAP A 225 (-2.9A);RAP A 225 (-3.5A);RAP A 225 (-3.9A);RAP A 225 (-3.4A);RAP A 225 (-4.6A);RAP A 225 ( 4.9A);None","0.41A","3kz7A-1pbkA:22.7","3kz7A-1pbkA:95.69"],["3O5R_A_FK5A1001_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","1pbk","FKBP25","Homo sapiens",8,"TYR A 135;ASP A 146;VAL A 171;ILE A 172;TRP A 175;TYR A 198;ILE A 208;PHE A 216","RAP A 225 (-3.9A);RAP A 225 (-3.0A);RAP A 225 (-3.5A);RAP A 225 (-3.9A);RAP A 225 (-3.4A);RAP A 225 (-4.6A);RAP A 225 ( 4.9A);None","0.30A","3o5rA-1pbkA:18.3","3o5rA-1pbkA:37.88"],["3O5R_A_FK5A1001_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","1pbk","FKBP25","Homo sapiens",8,"TYR A 135;ASP A 146;VAL A 171;ILE A 172;TYR A 198;LYS A 207;ILE A 208;PHE A 216","RAP A 225 (-3.9A);RAP A 225 (-3.0A);RAP A 225 (-3.5A);RAP A 225 (-3.9A);RAP A 225 (-4.6A);None;RAP A 225 ( 4.9A);None","0.54A","3o5rA-1pbkA:18.3","3o5rA-1pbkA:37.88"],["3UF8_A_FK5A114_1","UBIQUITIN-LIKE PROTEIN SMT3, PEPTIDYL-PROLYL CIS-TRANS ISOMERASE","1pbk","FKBP25","Homo sapiens",8,"TYR A 135;ASP A 146;VAL A 171;ILE A 172;TRP A 175;TYR A 198;ILE A 208;PHE A 216","RAP A 225 (-3.9A);RAP A 225 (-3.0A);RAP A 225 (-3.5A);RAP A 225 (-3.9A);RAP A 225 (-3.4A);RAP A 225 (-4.6A);RAP A 225 ( 4.9A);None","0.24A","3uf8A-1pbkA:18.1","3uf8A-1pbkA:26.96"],["3UQA_A_FK5A114_1","UBIQUITIN-LIKE PROTEIN SMT3, PEPTIDYL-PROLYL CIS-TRANS ISOMERASE","1pbk","FKBP25","Homo sapiens",8,"TYR A 135;ASP A 146;VAL A 171;ILE A 172;TRP A 175;TYR A 198;ILE A 208;PHE A 216","RAP A 225 (-3.9A);RAP A 225 (-3.0A);RAP A 225 (-3.5A);RAP A 225 (-3.9A);RAP A 225 (-3.4A);RAP A 225 (-4.6A);RAP A 225 ( 4.9A);None","0.31A","3uqaA-1pbkA:18.0","3uqaA-1pbkA:26.96"],["3UQB_A_FK5A114_1","UBIQUITIN-LIKE PROTEIN SMT3, PEPTIDYL-PROLYL CIS-TRANS ISOMERASE","1pbk","FKBP25","Homo sapiens",7,"TYR A 135;VAL A 171;ILE A 172;TRP A 175;TYR A 198;ILE A 208;PHE A 216","RAP A 225 (-3.9A);RAP A 225 (-3.5A);RAP A 225 (-3.9A);RAP A 225 (-3.4A);RAP A 225 (-4.6A);RAP A 225 ( 4.9A);None","0.26A","3uqbA-1pbkA:17.9","3uqbA-1pbkA:26.47"],["3VAW_A_FK5A114_1","UBIQUITIN-LIKE PROTEIN SMT3,PEPTIDYL-PROLYL CIS-TRANS ISOMERASE","1pbk","FKBP25","Homo sapiens",8,"TYR A 135;ASP A 146;VAL A 171;ILE A 172;TRP A 175;TYR A 198;ILE A 208;PHE A 216","RAP A 225 (-3.9A);RAP A 225 (-3.0A);RAP A 225 (-3.5A);RAP A 225 (-3.9A);RAP A 225 (-3.4A);RAP A 225 (-4.6A);RAP A 225 ( 4.9A);None","0.32A","3vawA-1pbkA:17.4","3vawA-1pbkA:26.96"],["4DRH_A_RAPA201_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","1pbk","FKBP25","Homo sapiens",8,"TYR A 135;ASP A 146;VAL A 171;ILE A 172;TRP A 175;TYR A 198;ILE A 208;PHE A 216","RAP A 225 (-3.9A);RAP A 225 (-3.0A);RAP A 225 (-3.5A);RAP A 225 (-3.9A);RAP A 225 (-3.4A);RAP A 225 (-4.6A);RAP A 225 ( 4.9A);None","0.39A","4drhA-1pbkA:17.3","4drhA-1pbkA:38.35"],["4DRH_D_RAPD201_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","1pbk","FKBP25","Homo sapiens",8,"TYR A 135;ASP A 146;VAL A 171;ILE A 172;TRP A 175;TYR A 198;ILE A 208;PHE A 216","RAP A 225 (-3.9A);RAP A 225 (-3.0A);RAP A 225 (-3.5A);RAP A 225 (-3.9A);RAP A 225 (-3.4A);RAP A 225 (-4.6A);RAP A 225 ( 4.9A);None","0.38A","4drhD-1pbkA:17.3","4drhD-1pbkA:38.35"],["4DRI_A_RAPA201_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP5","1pbk","FKBP25","Homo sapiens",8,"TYR A 135;ASP A 146;VAL A 171;ILE A 172;TRP A 175;TYR A 198;ILE A 208;PHE A 216","RAP A 225 (-3.9A);RAP A 225 (-3.0A);RAP A 225 (-3.5A);RAP A 225 (-3.9A);RAP A 225 (-3.4A);RAP A 225 (-4.6A);RAP A 225 ( 4.9A);None","0.33A","4driA-1pbkA:18.8","4driA-1pbkA:38.35"],["4DRJ_A_RAPA201_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP4","1pbk","FKBP25","Homo sapiens",8,"TYR A 135;ASP A 146;VAL A 171;ILE A 172;TRP A 175;TYR A 198;ILE A 208;PHE A 216","RAP A 225 (-3.9A);RAP A 225 (-3.0A);RAP A 225 (-3.5A);RAP A 225 (-3.9A);RAP A 225 (-3.4A);RAP A 225 (-4.6A);RAP A 225 ( 4.9A);None","0.26A","4drjA-1pbkA:19.1","4drjA-1pbkA:38.00"],["4DZ2_A_FK5A200_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE;PEPTIDYL-PROLYL CIS-TRANS ISOMERASE","1pbk","FKBP25","Homo sapiens",5,"PHE A 164;ILE A 172;TRP A 175;TYR A 198;PHE A 216","None;RAP A 225 (-3.9A);RAP A 225 (-3.4A);RAP A 225 (-4.6A);None","1.36A","4dz2A-1pbkA:17.9;4dz2B-1pbkA:17.9","4dz2A-1pbkA:41.32;4dz2B-1pbkA:41.32"],["4DZ2_A_FK5A200_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE;PEPTIDYL-PROLYL CIS-TRANS ISOMERASE","1pbk","FKBP25","Homo sapiens",8,"TYR A 135;ASP A 146;VAL A 171;ILE A 172;TRP A 175;TYR A 198;ILE A 208;PHE A 216","RAP A 225 (-3.9A);RAP A 225 (-3.0A);RAP A 225 (-3.5A);RAP A 225 (-3.9A);RAP A 225 (-3.4A);RAP A 225 (-4.6A);RAP A 225 ( 4.9A);None","0.31A","4dz2A-1pbkA:17.9;4dz2B-1pbkA:17.9","4dz2A-1pbkA:41.32;4dz2B-1pbkA:41.32"],["4DZ2_B_FK5B200_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE;PEPTIDYL-PROLYL CIS-TRANS ISOMERASE","1pbk","FKBP25","Homo sapiens",6,"PHE A 164;ILE A 172;TRP A 175;TYR A 198;ILE A 208;PHE A 216","None;RAP A 225 (-3.9A);RAP A 225 (-3.4A);RAP A 225 (-4.6A);RAP A 225 ( 4.9A);None","1.36A","4dz2A-1pbkA:17.9;4dz2B-1pbkA:17.9","4dz2A-1pbkA:41.32;4dz2B-1pbkA:41.32"],["4DZ2_B_FK5B200_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE;PEPTIDYL-PROLYL CIS-TRANS ISOMERASE","1pbk","FKBP25","Homo sapiens",8,"TYR A 135;ASP A 146;VAL A 171;ILE A 172;TRP A 175;TYR A 198;ILE A 208;PHE A 216","RAP A 225 (-3.9A);RAP A 225 (-3.0A);RAP A 225 (-3.5A);RAP A 225 (-3.9A);RAP A 225 (-3.4A);RAP A 225 (-4.6A);RAP A 225 ( 4.9A);None","0.32A","4dz2A-1pbkA:17.9;4dz2B-1pbkA:17.9","4dz2A-1pbkA:41.32;4dz2B-1pbkA:41.32"],["4DZ3_A_FK5A201_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE","1pbk","FKBP25","Homo sapiens",5,"PHE A 164;ILE A 172;TRP A 175;TYR A 198;PHE A 216","None;RAP A 225 (-3.9A);RAP A 225 (-3.4A);RAP A 225 (-4.6A);None","1.33A","4dz3A-1pbkA:18.1","4dz3A-1pbkA:41.32"],["4DZ3_A_FK5A201_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE","1pbk","FKBP25","Homo sapiens",8,"TYR A 135;ASP A 146;VAL A 171;ILE A 172;TRP A 175;TYR A 198;ILE A 208;PHE A 216","RAP A 225 (-3.9A);RAP A 225 (-3.0A);RAP A 225 (-3.5A);RAP A 225 (-3.9A);RAP A 225 (-3.4A);RAP A 225 (-4.6A);RAP A 225 ( 4.9A);None","0.32A","4dz3A-1pbkA:18.1","4dz3A-1pbkA:41.32"],["4DZ3_B_FK5B201_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE","1pbk","FKBP25","Homo sapiens",6,"PHE A 164;ILE A 172;TRP A 175;TYR A 198;ILE A 208;PHE A 216","None;RAP A 225 (-3.9A);RAP A 225 (-3.4A);RAP A 225 (-4.6A);RAP A 225 ( 4.9A);None","1.33A","4dz3B-1pbkA:18.1","4dz3B-1pbkA:41.32"],["4DZ3_B_FK5B201_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE","1pbk","FKBP25","Homo sapiens",8,"TYR A 135;ASP A 146;VAL A 171;ILE A 172;TRP A 175;TYR A 198;ILE A 208;PHE A 216","RAP A 225 (-3.9A);RAP A 225 (-3.0A);RAP A 225 (-3.5A);RAP A 225 (-3.9A);RAP A 225 (-3.4A);RAP A 225 (-4.6A);RAP A 225 ( 4.9A);None","0.31A","4dz3B-1pbkA:18.1","4dz3B-1pbkA:41.32"],["4LAX_A_FK5A301_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP4","1pbk","FKBP25","Homo sapiens",6,"PHE A 164;ILE A 172;TRP A 175;TYR A 198;ILE A 208;PHE A 216","None;RAP A 225 (-3.9A);RAP A 225 (-3.4A);RAP A 225 (-4.6A);RAP A 225 ( 4.9A);None","1.47A","4laxA-1pbkA:19.1","4laxA-1pbkA:33.15"],["4LAX_A_FK5A301_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP4","1pbk","FKBP25","Homo sapiens",8,"TYR A 135;ASP A 146;VAL A 171;ILE A 172;TRP A 175;LYS A 207;ILE A 208;PHE A 216","RAP A 225 (-3.9A);RAP A 225 (-3.0A);RAP A 225 (-3.5A);RAP A 225 (-3.9A);RAP A 225 (-3.4A);None;RAP A 225 ( 4.9A);None","0.71A","4laxA-1pbkA:19.1","4laxA-1pbkA:33.15"],["4LAX_A_FK5A301_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP4","1pbk","FKBP25","Homo sapiens",8,"TYR A 135;ASP A 146;VAL A 171;ILE A 172;TRP A 175;TYR A 198;ILE A 208;PHE A 216","RAP A 225 (-3.9A);RAP A 225 (-3.0A);RAP A 225 (-3.5A);RAP A 225 (-3.9A);RAP A 225 (-3.4A);RAP A 225 (-4.6A);RAP A 225 ( 4.9A);None","0.28A","4laxA-1pbkA:19.1","4laxA-1pbkA:33.15"],["4NNR_A_FK5A201_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP2;PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP2","1pbk","FKBP25","Homo sapiens",8,"TYR A 135;ASP A 146;VAL A 171;ILE A 172;TRP A 175;TYR A 198;ILE A 208;PHE A 216","RAP A 225 (-3.9A);RAP A 225 (-3.0A);RAP A 225 (-3.5A);RAP A 225 (-3.9A);RAP A 225 (-3.4A);RAP A 225 (-4.6A);RAP A 225 ( 4.9A);None","0.27A","4nnrA-1pbkA:15.6;4nnrB-1pbkA:15.6","4nnrA-1pbkA:38.62;4nnrB-1pbkA:38.62"],["4NNR_B_FK5B201_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP2","1pbk","FKBP25","Homo sapiens",8,"TYR A 135;ASP A 146;VAL A 171;ILE A 172;TRP A 175;TYR A 198;ILE A 208;PHE A 216","RAP A 225 (-3.9A);RAP A 225 (-3.0A);RAP A 225 (-3.5A);RAP A 225 (-3.9A);RAP A 225 (-3.4A);RAP A 225 (-4.6A);RAP A 225 ( 4.9A);None","0.26A","4nnrB-1pbkA:15.6","4nnrB-1pbkA:38.62"],["4ODO_A_FK5A205_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE SLYD","1pbk","FKBP25","Homo sapiens",6,"TYR A 135;ASP A 146;LEU A 162;ILE A 172;TYR A 198;PHE A 216","RAP A 225 (-3.9A);RAP A 225 (-3.0A);RAP A 225 (-4.8A);RAP A 225 (-3.9A);RAP A 225 (-4.6A);None","0.54A","4odoA-1pbkA:11.6","4odoA-1pbkA:27.10"],["4ODO_B_FK5B203_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE SLYD","1pbk","FKBP25","Homo sapiens",6,"TYR A 135;ASP A 146;LEU A 162;ILE A 172;TYR A 198;PHE A 216","RAP A 225 (-3.9A);RAP A 225 (-3.0A);RAP A 225 (-4.8A);RAP A 225 (-3.9A);RAP A 225 (-4.6A);None","0.52A","4odoB-1pbkA:11.4","4odoB-1pbkA:27.10"],["4ODO_C_FK5C204_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE SLYD","1pbk","FKBP25","Homo sapiens",6,"TYR A 135;ASP A 146;LEU A 162;ILE A 172;TYR A 198;PHE A 216","RAP A 225 (-3.9A);RAP A 225 (-3.0A);RAP A 225 (-4.8A);RAP A 225 (-3.9A);RAP A 225 (-4.6A);None","0.51A","4odoC-1pbkA:11.2","4odoC-1pbkA:27.10"],["4ODR_A_FK5A201_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE SLYD, PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP1A CHIMERA;PEPTIDYL-PROLYL CIS-TRANS ISOMERASE SLYD, PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP1A CHIMERA","1pbk","FKBP25","Homo sapiens",7,"TYR A 135;ASP A 146;LEU A 162;ILE A 172;TYR A 198;ILE A 208;PHE A 216","RAP A 225 (-3.9A);RAP A 225 (-3.0A);RAP A 225 (-4.8A);RAP A 225 (-3.9A);RAP A 225 (-4.6A);RAP A 225 ( 4.9A);None","0.49A","4odrA-1pbkA:13.2;4odrB-1pbkA:13.2","4odrA-1pbkA:28.06;4odrB-1pbkA:28.06"],["4ODR_B_FK5B201_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE SLYD, PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP1A CHIMERA;PEPTIDYL-PROLYL CIS-TRANS ISOMERASE SLYD, PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP1A CHIMERA","1pbk","FKBP25","Homo sapiens",6,"TYR A 135;ASP A 146;LEU A 162;ILE A 172;TYR A 198;PHE A 216","RAP A 225 (-3.9A);RAP A 225 (-3.0A);RAP A 225 (-4.8A);RAP A 225 (-3.9A);RAP A 225 (-4.6A);None","0.48A","4odrA-1pbkA:13.2;4odrB-1pbkA:13.2","4odrA-1pbkA:28.06;4odrB-1pbkA:28.06"],["4QT2_A_RAPA202_1","FK506-BINDING PROTEIN (FKBP)-TYPE PEPTIDYL-PROPYL ISOMERASE","1pbk","FKBP25","Homo sapiens",8,"TYR A 135;ASP A 146;VAL A 171;ILE A 172;TRP A 175;TYR A 198;ILE A 208;PHE A 216","RAP A 225 (-3.9A);RAP A 225 (-3.0A);RAP A 225 (-3.5A);RAP A 225 (-3.9A);RAP A 225 (-3.4A);RAP A 225 (-4.6A);RAP A 225 ( 4.9A);None","0.31A","4qt2A-1pbkA:18.5","4qt2A-1pbkA:37.50"],["4QT3_A_RAPA202_1","FK506-BINDING PROTEIN (FKBP)-TYPE PEPTIDYL-PROPYL ISOMERASE","1pbk","FKBP25","Homo sapiens",8,"TYR A 135;ASP A 146;VAL A 171;ILE A 172;TRP A 175;TYR A 198;ILE A 208;PHE A 216","RAP A 225 (-3.9A);RAP A 225 (-3.0A);RAP A 225 (-3.5A);RAP A 225 (-3.9A);RAP A 225 (-3.4A);RAP A 225 (-4.6A);RAP A 225 ( 4.9A);None","0.37A","4qt3A-1pbkA:17.4","4qt3A-1pbkA:33.80"],["5B8I_C_FK5C201_3","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE","1pbk","FKBP25","Homo sapiens",8,"TYR A 135;ASP A 146;VAL A 171;ILE A 172;TRP A 175;TYR A 198;ILE A 208;PHE A 216","RAP A 225 (-3.9A);RAP A 225 (-3.0A);RAP A 225 (-3.5A);RAP A 225 (-3.9A);RAP A 225 (-3.4A);RAP A 225 (-4.6A);RAP A 225 ( 4.9A);None","0.34A","5b8iC-1pbkA:18.9","5b8iC-1pbkA:41.98"],["5D75_A_FK5A301_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP3","1pbk","FKBP25","Homo sapiens",9,"LEU A 162;VAL A 171;ILE A 172;TRP A 175;TYR A 198;GLN A 203;ALA A 206;ILE A 208;PHE A 216","RAP A 225 (-4.8A);RAP A 225 (-3.5A);RAP A 225 (-3.9A);RAP A 225 (-3.4A);RAP A 225 (-4.6A);None;RAP A 225 ( 3.9A);RAP A 225 ( 4.9A);None","1.05A","5d75A-1pbkA:22.0","5d75A-1pbkA:100.00"],["5D75_A_FK5A301_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP3","1pbk","FKBP25","Homo sapiens",10,"TYR A 135;ASP A 146;LEU A 162;VAL A 171;ILE A 172;TRP A 175;TYR A 198;ALA A 206;ILE A 208;PHE A 216","RAP A 225 (-3.9A);RAP A 225 (-3.0A);RAP A 225 (-4.8A);RAP A 225 (-3.5A);RAP A 225 (-3.9A);RAP A 225 (-3.4A);RAP A 225 (-4.6A);RAP A 225 ( 3.9A);RAP A 225 ( 4.9A);None","0.75A","5d75A-1pbkA:22.0","5d75A-1pbkA:100.00"],["5GPG_A_RAPA301_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP3","1pbk","FKBP25","Homo sapiens",10,"TYR A 135;ASP A 146;LEU A 162;LYS A 170;VAL A 171;ILE A 172;TRP A 175;TYR A 198;ILE A 208;PHE A 216","RAP A 225 (-3.9A);RAP A 225 (-3.0A);RAP A 225 (-4.8A);RAP A 225 (-2.9A);RAP A 225 (-3.5A);RAP A 225 (-3.9A);RAP A 225 (-3.4A);RAP A 225 (-4.6A);RAP A 225 ( 4.9A);None","0.54A","5gpgA-1pbkA:21.9","5gpgA-1pbkA:100.00"],["5GPG_A_RAPA301_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP3","1pbk","FKBP25","Homo sapiens",10,"TYR A 135;ASP A 146;LEU A 162;VAL A 171;ILE A 172;TRP A 175;TYR A 198;ALA A 206;ILE A 208;PHE A 216","RAP A 225 (-3.9A);RAP A 225 (-3.0A);RAP A 225 (-4.8A);RAP A 225 (-3.5A);RAP A 225 (-3.9A);RAP A 225 (-3.4A);RAP A 225 (-4.6A);RAP A 225 ( 3.9A);RAP A 225 ( 4.9A);None","0.56A","5gpgA-1pbkA:21.9","5gpgA-1pbkA:100.00"],["5HKG_A_RAPA201_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP1B","1pbk","FKBP25","Homo sapiens",7,"TYR A 135;ASP A 146;VAL A 171;ILE A 172;TYR A 198;ILE A 208;PHE A 216","RAP A 225 (-3.9A);RAP A 225 (-3.0A);RAP A 225 (-3.5A);RAP A 225 (-3.9A);RAP A 225 (-4.6A);RAP A 225 ( 4.9A);None","0.38A","5hkgA-1pbkA:19.1","5hkgA-1pbkA:42.50"],["5HUA_A_FK5A201_1","FK506-BINDING PROTEIN 1","1pbk","FKBP25","Homo sapiens",7,"TYR A 135;ASP A 146;VAL A 171;ILE A 172;TRP A 175;TYR A 198;PHE A 216","RAP A 225 (-3.9A);RAP A 225 (-3.0A);RAP A 225 (-3.5A);RAP A 225 (-3.9A);RAP A 225 (-3.4A);RAP A 225 (-4.6A);None","0.25A","5huaA-1pbkA:19.6","5huaA-1pbkA:42.28"],["5HW8_A_FK5A201_1","FK506-BINDING PROTEIN 1;FK506-BINDING PROTEIN 1","1pbk","FKBP25","Homo sapiens",7,"TYR A 135;ASP A 146;VAL A 171;ILE A 172;TRP A 175;TYR A 198;ILE A 208","RAP A 225 (-3.9A);RAP A 225 (-3.0A);RAP A 225 (-3.5A);RAP A 225 (-3.9A);RAP A 225 (-3.4A);RAP A 225 (-4.6A);RAP A 225 ( 4.9A)","0.45A","5hw8A-1pbkA:17.9;5hw8D-1pbkA:18.1","5hw8A-1pbkA:40.00;5hw8D-1pbkA:40.00"],["5HW8_B_FK5B201_1","FK506-BINDING PROTEIN 1","1pbk","FKBP25","Homo sapiens",7,"TYR A 135;ASP A 146;VAL A 171;TRP A 175;TYR A 198;ILE A 208;PHE A 216","RAP A 225 (-3.9A);RAP A 225 (-3.0A);RAP A 225 (-3.5A);RAP A 225 (-3.4A);RAP A 225 (-4.6A);RAP A 225 ( 4.9A);None","0.40A","5hw8B-1pbkA:17.9","5hw8B-1pbkA:40.00"],["5HW8_C_FK5C201_1","FK506-BINDING PROTEIN 1;FK506-BINDING PROTEIN 1","1pbk","FKBP25","Homo sapiens",8,"TYR A 135;ASP A 146;VAL A 171;ILE A 172;TRP A 175;TYR A 198;LEU A 214;PHE A 216","RAP A 225 (-3.9A);RAP A 225 (-3.0A);RAP A 225 (-3.5A);RAP A 225 (-3.9A);RAP A 225 (-3.4A);RAP A 225 (-4.6A);None;None","0.41A","5hw8C-1pbkA:17.8;5hw8H-1pbkA:14.8","5hw8C-1pbkA:40.00;5hw8H-1pbkA:40.00"],["5HW8_D_FK5D201_1","FK506-BINDING PROTEIN 1","1pbk","FKBP25","Homo sapiens",8,"TYR A 135;ASP A 146;VAL A 171;ILE A 172;TRP A 175;TYR A 198;ILE A 208;PHE A 216","RAP A 225 (-3.9A);RAP A 225 (-3.0A);RAP A 225 (-3.5A);RAP A 225 (-3.9A);RAP A 225 (-3.4A);RAP A 225 (-4.6A);RAP A 225 ( 4.9A);None","0.40A","5hw8D-1pbkA:18.1","5hw8D-1pbkA:40.00"],["5HW8_E_FK5E201_1","FK506-BINDING PROTEIN 1","1pbk","FKBP25","Homo sapiens",7,"TYR A 135;ASP A 146;VAL A 171;ILE A 172;TRP A 175;TYR A 198;ILE A 208","RAP A 225 (-3.9A);RAP A 225 (-3.0A);RAP A 225 (-3.5A);RAP A 225 (-3.9A);RAP A 225 (-3.4A);RAP A 225 (-4.6A);RAP A 225 ( 4.9A)","1.46A","5hw8E-1pbkA:18.3","5hw8E-1pbkA:40.00"],["5HW8_E_FK5E201_1","FK506-BINDING PROTEIN 1","1pbk","FKBP25","Homo sapiens",7,"TYR A 135;ASP A 146;VAL A 171;ILE A 172;TRP A 175;TYR A 198;PHE A 216","RAP A 225 (-3.9A);RAP A 225 (-3.0A);RAP A 225 (-3.5A);RAP A 225 (-3.9A);RAP A 225 (-3.4A);RAP A 225 (-4.6A);None","0.42A","5hw8E-1pbkA:18.3","5hw8E-1pbkA:40.00"],["5HW8_F_FK5F201_1","FK506-BINDING PROTEIN 1;FK506-BINDING PROTEIN 1;FK506-BINDING PROTEIN 1","1pbk","FKBP25","Homo sapiens",7,"TYR A 135;ASP A 146;VAL A 171;ILE A 172;TRP A 175;TYR A 198;PHE A 216","RAP A 225 (-3.9A);RAP A 225 (-3.0A);RAP A 225 (-3.5A);RAP A 225 (-3.9A);RAP A 225 (-3.4A);RAP A 225 (-4.6A);None","0.41A","5hw8B-1pbkA:17.9;5hw8F-1pbkA:15.0;5hw8G-1pbkA:17.4","5hw8B-1pbkA:40.00;5hw8F-1pbkA:40.00;5hw8G-1pbkA:40.00"],["5HW8_G_FK5G201_2","FK506-BINDING PROTEIN 1","1pbk","FKBP25","Homo sapiens",7,"TYR A 135;ASP A 146;VAL A 171;ILE A 172;TRP A 175;TYR A 198;ILE A 208","RAP A 225 (-3.9A);RAP A 225 (-3.0A);RAP A 225 (-3.5A);RAP A 225 (-3.9A);RAP A 225 (-3.4A);RAP A 225 (-4.6A);RAP A 225 ( 4.9A)","1.41A","5hw8G-1pbkA:17.4","5hw8G-1pbkA:40.00"],["5HW8_G_FK5G201_2","FK506-BINDING PROTEIN 1","1pbk","FKBP25","Homo sapiens",8,"TYR A 135;ASP A 146;VAL A 171;ILE A 172;TRP A 175;TYR A 198;ILE A 208;PHE A 216","RAP A 225 (-3.9A);RAP A 225 (-3.0A);RAP A 225 (-3.5A);RAP A 225 (-3.9A);RAP A 225 (-3.4A);RAP A 225 (-4.6A);RAP A 225 ( 4.9A);None","0.38A","5hw8G-1pbkA:17.4","5hw8G-1pbkA:40.00"],["5HW8_H_FK5H201_1","FK506-BINDING PROTEIN 1","1pbk","FKBP25","Homo sapiens",6,"TYR A 135;ASP A 146;VAL A 171;ILE A 172;TRP A 175;PHE A 216","RAP A 225 (-3.9A);RAP A 225 (-3.0A);RAP A 225 (-3.5A);RAP A 225 (-3.9A);RAP A 225 (-3.4A);None","0.53A","5hw8H-1pbkA:14.8","5hw8H-1pbkA:40.00"],["5HWC_A_FK5A201_1","FK506-BINDING PROTEIN 1A","1pbk","FKBP25","Homo sapiens",8,"TYR A 135;ASP A 146;VAL A 171;ILE A 172;TRP A 175;TYR A 198;ILE A 208;PHE A 216","RAP A 225 (-3.9A);RAP A 225 (-3.0A);RAP A 225 (-3.5A);RAP A 225 (-3.9A);RAP A 225 (-3.4A);RAP A 225 (-4.6A);RAP A 225 ( 4.9A);None","0.30A","5hwcA-1pbkA:19.6","5hwcA-1pbkA:43.70"],["5JLC_A_1YNA602_2","LANOSTEROL 14-ALPHA DEMETHYLASE","1pbk","FKBP25","Homo sapiens",4,"GLY A 142;THR A 143;GLY A 119;LEU A 190","None","0.91A","5jlcA-1pbkA:undetectable","5jlcA-1pbkA:12.90"],["6MKE_A_FK5A201_0","PEPTIDYLPROLYL ISOMERASE","1pbk","FKBP25","Homo sapiens",8,"TYR A 135;ASP A 146;VAL A 171;ILE A 172;TRP A 175;TYR A 198;ILE A 208;PHE A 216","RAP A 225 (-3.9A);RAP A 225 (-3.0A);RAP A 225 (-3.5A);RAP A 225 (-3.9A);RAP A 225 (-3.4A);RAP A 225 (-4.6A);RAP A 225 ( 4.9A);None","0.40A","6mkeA-1pbkA:18.1;6mkeD-1pbkA:18.1","6mkeA-1pbkA:36.99;6mkeD-1pbkA:36.99"],["6MKE_B_FK5B201_0","PEPTIDYLPROLYL ISOMERASE","1pbk","FKBP25","Homo sapiens",8,"TYR A 135;ASP A 146;VAL A 171;ILE A 172;TRP A 175;TYR A 198;ILE A 208;PHE A 216","RAP A 225 (-3.9A);RAP A 225 (-3.0A);RAP A 225 (-3.5A);RAP A 225 (-3.9A);RAP A 225 (-3.4A);RAP A 225 (-4.6A);RAP A 225 ( 4.9A);None","0.40A","6mkeB-1pbkA:18.1;6mkeC-1pbkA:18.3","6mkeB-1pbkA:36.99;6mkeC-1pbkA:36.99"],["6MKE_C_FK5C201_1","PEPTIDYLPROLYL ISOMERASE","1pbk","FKBP25","Homo sapiens",8,"TYR A 135;ASP A 146;VAL A 171;ILE A 172;TRP A 175;TYR A 198;ILE A 208;PHE A 216","RAP A 225 (-3.9A);RAP A 225 (-3.0A);RAP A 225 (-3.5A);RAP A 225 (-3.9A);RAP A 225 (-3.4A);RAP A 225 (-4.6A);RAP A 225 ( 4.9A);None","0.33A","6mkeC-1pbkA:18.3","6mkeC-1pbkA:36.99"],["6MKE_D_FK5D201_1","PEPTIDYLPROLYL ISOMERASE","1pbk","FKBP25","Homo sapiens",8,"TYR A 135;ASP A 146;VAL A 171;ILE A 172;TRP A 175;TYR A 198;ILE A 208;PHE A 216","RAP A 225 (-3.9A);RAP A 225 (-3.0A);RAP A 225 (-3.5A);RAP A 225 (-3.9A);RAP A 225 (-3.4A);RAP A 225 (-4.6A);RAP A 225 ( 4.9A);None","0.39A","6mkeD-1pbkA:18.1","6mkeD-1pbkA:36.99"]]